Symposia

Symposia

The Symposia are included in the registration fee. During the on-line Registration process, you will be asked to confirm sessions attendance.


 

S1 | Neurodegenerative Dementing Disorders, Brain Over-excitation, and EEG Signatures: Preclinical and Clinical Evidence
Day: Wednesday, June 5
Scheduled hour: 14.30 – 16.00 *** New starting time
Chair / Organiser: Claudio Babiloni

More info

Background: 1) Temporal lobe Epilepsy and Alzheimer’s disease (AD) show similarities of high clinical interest. In AD patients, the incidence of convulsive seizures is 10 times higher than healthy controls and 87 times more frequent with “early-onset” disease manifestation; 2) cognitive decline starts 5.5 years earlier in AD patients with epilepsy than AD controls; and 3) hippocampus hyperactivity is a risk factor for mild cognitive impairment (MCI) and rationalized an antiepileptic preventive treatment trial in MCI using Levetiracetam (NCT01044758).
Aims: show new evidence about the prevalence of EEG signatures of over-excitation of cerebral cortex and abnormal functional connectivity networks in AD and Lewy body diseases.

Chairman (Presenter):  Claudio Babiloni (Sapienza University of Rome, Italy).
1 ) Characterization of epileptic spiking associated with brain amyloidosis in APP/PS1 mice as new readouts in preclinical treatment trials. By Prof. Heikki Tanila, Professor of Translational Neuroscience (University of Eastern Finland, Kuopio, Finland).
2 ) Effects of Ab42 in the brain and abnormal cortical excitability as revealed by cortical EEG biomarkers in patients with preclinical and prodromal Alzheimer’s disease. By Dr. Claudio Del Percio, Researcher of Neurophysiology (Sapienza University of Rome, Italy).
3 ) Effects of dopamine depletion in the brain and abnormal cortical excitability as revealed by cortical EEG biomarkers in patients with Lewy Body diseases. By Dr. Laura Bonanni, Researcher of Neurology (University of Chieti-Pescara “G. D’Annunzio”, Italy).

S2 | Brainstem SIG Symposium – State of the art in intraoperative monitoring of the brainstem
Day: Wednesday, June 5
Scheduled hour: 12.30 – 14.00
Chair / Organiser: Satu Jääskeläinen

More info

1 ) Monitoring trigeminal, facial, and acoustic nerves during posterior fossa surgery. By Gemma Pérez-Fajardo (Barcelona, Spain).
2 ) Monitoring and predicting efficacy of hemifacial spasm surgery. By Pepijn van den Munckhof (Amsterdam, Netherlands).
3 ) Novel techniques for intraoperative monitoring of the lower brainstem. By Vedran Deletis (Split, Croatia).

This first Brainstem SIG symposium gathers novel and standard neurophysiologic techniques available for intraoperative monitoring of the brainstem and most of the cranial nerves during different types of intracranial neurosurgery. It covers less often used methods for monitoring hemifacial spasm surgery, in addition to commonly used ENMG and evoked potential techniques for posterior fossa surgery as well as novel and innovative methods utilizing e.g. laryngeal ENMG and reflex recordings techniques to prevent nerve damage at the lower brainstem level in the operating room.

S3 | Spontaneous and stimulation dependent markers of the effectiveness of Anterior Nucleus of Thalamus-DBS treatment
Day: Wednesday, June 5
Scheduled hour: 14.30 – 16.00
Chair / Organiser: Daniel Fabo

More info

Anterior Nucleus of Thalamus (ANT) DBS treatment is an emerging invasive neurostimulation option for drug resistant epilepsy. The efficacy is variable and the identification of the responsive patient group is highly needed based on the invasive nature and high costs of the intervention. In this symposium we review the available data for invasive and non invasive markers for DBS efficacy, and present our own results based on invasive recordings from the human Anterior Nucleus of Thalamus (ANT).

1 ) Epileptiform activities in the Anterior Nucleus of Thalamus. By Daniel Fabo, NICN, Budapest, Hungary.
2 ) Detailed analysis and high frequency activities of the Anterior Nucleus of Thalamus. By Ivan Rektor, CEITEC, Brno, Czech Republic.
3 ) Stimulation biomarkers for Anterior Nucleus of Thalamus-DBS. By Emilia Toth, UAB, Birmingham, AL, USA.

S4 | Evoked potentials and their clinical implications in CNS diseases
Day: Wednesday, June 5
Scheduled hour: 12.30 – 14.00 *** New starting time
Chair / Organiser: Anna Pokryszko-Dragan

More info

1 ) Evoked potentials as a monitoring tool in CNS diseases. By MD, PhD, Ass. Prof. Beata Zakrzewska-Pniewska and MD, PhD Monika Nojszewska.
2 ) P300 potential in the assessment of cognitive performance in CNS diseases. By MD, PhD, Ass. Prof. Anna Pokryszko-Dragan.

The first presentation concerns evoked potentials (EP) as a monitoring tool in CNS diseases. EP reveal normal or altered conduction in selected tracts of the central nervous system in a quantifiable way. Since alteration of signal conduction is the main mechanism of symptoms and signs in many CNS disorders, especially in multiple sclerosis (MS), multimodal EP may serve as a representative measure of the functional impairment in such diseases. Moreover, EP have been shown to be predictive for diseases course, and thus might help to select patient groups at high risk of progression for clinical trials. EP can detect deterioration, as well as improvement of impulse propagation, independently from the mechanism causing the change. Therefore, they might be candidates for biomarkers in many CNS disorders. In the second presentation the role of event-related potentials  will be  highlighted in the assessment of cognitive performance, with a special regard to P300 component. The examples will be shown of  P300 evaluation , complementary to neuropsychological tests, in the patients with primary CNS disorders as well as with CNS involvement in the course of systemic diseases. The pros and cons of the method and its potential future applications will be discussed

S5 | The Construction of Pain
Day: Thursday, June 6
Scheduled hour: 11.00 – 12.30
Chair / Organiser: Luis García-Larrea

More info

The Symposium will discuss how the aversive experience we call “pain” emerges from the coordinated activation of multiple brain areas.
Luis Garcia-Larrea will describe the so-called “pain matrix” as a fluid system of several interacting networks. Initial processing in a ‘nociceptive matrix’ receiving ascending input leads to activation of second-order structures supporting ‘salience’ attributes, the passage from pre-conscious nociception to conscious pain, and encoding in memory systems.
Hélène Bastuji will discuss data from intracortical EEG, illustrating that nociceptive processing is initiated in parallel in sensory and limbic areas, to converge in the anterior insula in less than one second, and underscoring the role of this region in integrating limbic with sensory input to initiate a perceptual decision on the stimulus ‘painfulness’. 
Markus Ploner will discuss approaches to cortical nociceptive processing via the study of brain oscillations. Conscious pain depends on integration of brain activity across different areas, and functional connectivity between sensory and high-level networks should determinant for access to consciousness. Interactions between neural oscillations, together with the implementation of graph theory methods are likely solutions to gain access to local and global levels of processing, thus allowing the study of normal and abnormal pain with non-invasive measures.

Speakers:
1 ) Luis García-Larrea (France)
2 ) Hélène Bastuji (France)
3 ) Markus Ploner (Germany)

S6 | Diagnosing amyotrophic lateral sclerosis
Day: Thursday, June 6
Scheduled hour: 11.00 – 12.30
Chair / Organiser: Birger Johnsen

More info

1 ) Diagnostic criteria in ALS, a review; by Birger Johnsen.
2 ) Application of diagnostic criteria in individual cases: practical problems; by Mamede De Carvalho.
3 ) New techniques to support the diagnosis of ALS; by Hatice Tankisi.

The diagnosis of amyotrophic lateral sclerosis (ALS) is clinical and relies on the presence of progressing disease with both upper motor neuron (UMN) and lower motor neuron (LMN) involvement, and the exclusion of other diseases. The «revised El Escorial criteria» (rEEC) has proposed an electrophysiological algorithm for supporting diagnosis, which was refined in the recent «Awaji criteria» (AC) with the intention of facilitate earlier diagnosis. The criteria have a high specificity, lack sensitivity although most studies show a higher sensitivity of the AC than the rEEC, and have a rather large inter-rater variation when used by untrained physicians indicating that their use may require training. Development of a reliable objective method for detection of UMN involvement is the most critical item for improvement of diagnostic sensitivity. This symposium will review current criteria, encompass their potentialities and limitations including their correct application and incorporation with clinical findings, and finally review promising new techniques for diagnosing and monitoring of ALS as transcranial magnetic stimulation, the novel motor unit number estimation (MUNE) method, MScanFit MUNE, ultrasound and neuroimaging. The session will be interactive with the presentation of a number of clinical vignettes regarding diagnostic categorization, underlying difficulties, and strategies to overcome practical problems.

S7 | Advanced technologies in clinical neurophysiology
Day: Thursday, June 6
Scheduled hour: 11.00 – 12.30
Chair / Organiser: Antonio Suppa

More info

1 ) Wearable sensors in Parkinson’s disease. By A. Suppa (Sapienza University of Rome, Italy).
2 ) Adaptive and closed-loop DBS in Parkinson’s disease. By R. Eleopra (Foundation of the Carlo Besta Neurological Institute, Milan, Italy).
3 ) A wearable robotic sixth finger for grasping recovery in hand paresis. By S. Rossi (University of Siena, Italy).

Symposium description:
Antonio Suppa will introduce and discuss the more advanced wireless technologies currently available for objective long-term monitoring of motor symptoms in PD.
Roberto Eleopra will discuss the more advanced technologies for possible closed-loop or adaptive DBS strategies in patients with PD.
Simone Rossi will discuss the emerging technologies for robotic-assisted neurorehabilitation in order to promote motor recovery in patients with stroke.

S8 | Quantified Measures for Motor Unit’s Bioelectrical Activity
Day: Thursday, June 6
Scheduled hour: 13.30 – 15.00
Chair / Organiser: Mehmet Baris Baslo

More info

1 ) Extracting quantified information from MUP configuration: Quantitative MUP analysis macro and scanning EMG. By M.B. Baslo, Prof. Dr, M.D, Istanbul University, Istanbul Medical Faculty, Department of Neurology, Turkey.
2 ) Activation of motor units: Recruitment and interference pattern analysis. By E. Stalberg, Prof. Dr, M.D, PhD, Uppsala University, Department of Neuroscience, Sweden.
3 ) Towards estimating the numbers of motor units: from configuration to quantity. By A.E. Oge, Prof. Dr, M.D, Istanbul University, Istanbul Medical Faculty, Department of Neurology, Turkey.
4 ) MUNIX. By S. Nandedkar, PhD, Natus Medical Incorporated, Department of Neurology, USA.

Description: This lecture aims to depict the principles of motor unit electrophysiology in health and disease by stating the pros and cons of both basic and advanced methods. The temporal and spatial features of motor unit action potential revealed by quantitative MUP analysis, macro EMG and scanning EMG will be discussed. Along with, recruitment properties of motor units to voluntary contraction and interference pattern analysis will be reviewed. Methods for counting the number of motor units by means of both estimation methods and MUNIX will be presented.

S9 | Can salience mask the genuine nociceptive brain activity?
Day: Thursday, June 6
Scheduled hour: 13.30 – 15.00
Chair / Organiser: Massimiliano Valeriani

More info

1 ) Physiology of the so-called “Pain Matrix”. By Ulf Baumgaertner, Department of Neurophysiology, Heidelberg University, Germany.
2 ) Is the cerebral cortex stimulation painful? By Laura Mazzola, Service épilepsie, sommeil et explorations fonctionnelles neuropédiatriques, HFME, Lyon, France.
3 ) “Pain Matrix” or “Salience Matrix”? That is the question. By Marina de Tommaso, Applied Neurophysiology and Pain Unit, Bari University, Italy.
Chairman: Massimiliano Valeriani, Neurology, Ospedale Pediatrico Bambino Gesú, Rome, Italy.

The network of the cortical areas processing the nociceptive input is commonly known as “Pain Matrix”. In the last decades, new neuroimaging and neurophysiological techniques have increased our knowledge about the physiology of these brain regions. However, the concept itself of “Pain Matrix” has been recently challenged by studies which showed that the cortical activities following a painful stimulation can be evoked by salient non-painful stimuli. The hypothesis has been made that the pattern of cerebral activation, traditionally considered as a marker of pain perception, is a mere expression of the salience of the incoming input, independently of its nociceptive quality. The major aim of this symposium will be to compare the elements in favor of the existence of a specific pain representation within the brain with those which are against this view.

S10 | Applications of novel therapeutic transcranial magnetic stimulation techniques
Day: Saturday, June 8 *** New date
Scheduled hour: 09.00 – 10.30 *** New time
Chair / Organiser: Leticia Leocani

More info

1 ) Deep transcranial magnetic stimulation. Advantages and disadvantages. By Letizia Leocani, Hospital San Raffaele, Milano, Italy.
2 ) Transcranial static magnetic stimulation. Mode of action and future perspectives. By Antonio Oliviero, Hospital de Parapléjicos, Toledo, Spain.
3 ) Single pulse transcranial magnetic and other forms of stimulation for migraine. By Francesca Puledda, Institute of Neuroscience, King’s College, London, UK.

Transcranial magnetic stimulation has been used as a therapeutic method for more than 30 years. New forms of stimulation have appeared in the recent past that have been selectively used, or have shown the potential for use, in certain disorders. The H-coil produces stimulation centered in the depth of the brain. Letizia Leocani will present and discuss the advantages and disadvantages of it and the disorders in which the deep H-coil may be more suitable. A magnet over the scalp has shown to induce a change in brain excitability. Antonio Oliviero will comment on mode of action and future perspectives for clinical application. Finally, many non-pharmacological types of therapy have been proposed for migraine, including a single-pulse portable TMS. Francesca Puledda will review these therapeutic options.

S11 | Changes in Axonal Excitability in Neurological Disease
Day: Thursday, June 6
Scheduled hour: 16.30 – 18.00
Chair / Organiser: David Burke / Christian Krarup

More info

Co-Chairs: David Burke and Christian Krarup
Speakers:
1 ) David Burke: Introduction to threshold tracking.
2 ) Hessel Franssen: Axonal properties in peripheral nerve disease.
3 ) Dirk Czesnik: Axonal changes in motor hyperexcitability syndromes. 
4 ) Christian Krarup: Altered Na+ channel expression in mouse models of CMT.

This symposium will address the clinical application of threshold tracking techniques to diseases of the peripheral and central nervous system. The Introduction to threshold tracking will provide essential information about the techniques used to study axonal excitability in human subjects in vivo, data essential for the understanding of subsequent talks. Professor Franssen will focus on the changes in axonal excitability in common polyneuropathies, and Dr Czesnik will address changes in motor axon excitability that are presumably the result of plastic changes in the properties of the innervating motoneurons. Professor Krarup will focus on disordered Na+ channel function in a validated mouse model of Charcot-Marie-Tooth disease, showing how blocking Na+ channel function can ameliorate the deficit in this model.

S12 | Human brain networks in physiological and pathological aging: graph theory application
Day: Thursday, June 6
Scheduled hour: 16.30 – 18.00
Chair / Organiser: Fabrizio Vecchio

More info

1 ) Brain plasticity and connectivity: methods and applications to EEG data
Francesca Miraglia ( Brain Connectivity Laboratory, IRCCS San Raffaele Pisana, Roma, Italy )
2 ) Brain networks connectivity in physiological and pathological aging during rest and task
Fabrizio Vecchio ( Brain Connectivity Laboratory, IRCCS San Raffaele Pisana, Roma, Italy )
3 ) Connectivity in neurodegeneration
Paolo Maria Rossini ( IRCCS Gemelli, Roma, Italy )

Human behavior and cognition are characterized by engagement of functional distributed networks within the brain. Such networks organization is especially significant in physiological and pathological aging and requires a high degree of intra-modal and inter-modal integration of information flow arriving from several, different and often remote brain sources. These networks dynamically connect adjacent and/or remote cortical neuronal assemblies via cortico-cortical connections. A novel approach, applying concepts from graph theory to neurophysiological data, is a promising new way to characterize brain activity, providing a method to evaluate whether functional connectivity patterns between brain areas resemble the organization of theoretically efficient, flexible or robust networks, based on strength of synchronization of different brain regions. The present proposed symposium is structured in three communication that summarizes the possible aspect of connectivity analyses, including EEG graph theory, in both physiological and pathological aging. Specifically, the symposium will be opened by a brief exploration of the modern techniques for the study of brain connectivity. It will be investigated brain connectivity in physiological aging by graph theoretical analysis of resting-state EEG recordings. Furthermore, it will be illustrated possible way to investigate and diagnosticate neurodegeneration such as Alzheimer’s disease through the study of the brain connectivity modulation

S13 | Entrapment neuropathies, updated diagnostic electrophysiological techniques
Day: Thursday, June 6
Scheduled hour: 16.30 – 18.00
Chair / Organiser: Ann Hanafy

More info

1 ) Clinical and Electrophysiological tips in entrapment neuropathies; by Prof Dr Ann Hanafy.
2 ) Combination of clinical provocative techniques with the electrophysiological study, an attempt to increase the diagnostic yield in diagnosis of early CTS; by Prof Dr Ayat Allah Farouk Hussein.
3 ) Value of stimulated SFEMG in diagnosis of early CTS; by Prof Dr Ayat Allah Farouk Hussein. 
4 ) Therapeutic role of repetitive peripheral magnetic stimulation in Carpal Tunnel Syndrome; by Prof Dr Amira M. El Gohary.

The symposium considers the value of neurophysiological, clinical and provocative tests in the diagnosis of entrapment neuropathies. In the first lecture, experience in combining neurophysiological and clinical techniques will be related. The remaining three talks focus on Carpal Tunnel Syndrome. The first of these compares the value of neurophysiology and provocative tests while the second considers the utility of single fibre EMG in the diagnosis of early CTS. The last lecture will give data on the usefulness of repetitive magnetic stimulation for the alleviation of pain in CTS

S14 | Myths and truths of high frequency oscillations (HFO) as markers of epileptogenic tissue
Day: Friday, June 7
Scheduled hour: 08.00 – 09.30 *** New starting time
Chair / Organiser: Milan Brazdil

More info

1 ) Options in physiology, by Premysl Jiruska, The Czech Academy of Sciences, Dept. of Developmental Epileptology, Prague, Czech Rep.
2 ) Interictal very high-frequency oscillations; by Milan Brazdil, Brno Epilepsy Center, Brno, Czech Rep.
3 ) Neuronal action potentials in HFO that predict seizure outcome; by Johannes Sarnthein, Neurosurgery Department, University of Zurich, Switzerland.
4 ) HFO to guide epilepsy surgery in a prospective trial; by Maeike Zijlmans, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands.

Symposium description: The quest for high-frequency oscillations (HFO) as biomarkers of epileptogenic tissue has led to ever-increasing frequencies but has cast doubt on their physiological plausibility and their clinical applicability. In this symposium, we will first present controversial physiological recordings to elucidate the physiological origin of HFO and discuss their role in epileptogenicity. Are HFO related to neuronal action potentials or mere effects of signal filtering? To address clinical relevance, we will then ask whether and how HFO can be defined prospectively to predict post-surgical seizure outcome. Is the experts’ agreement on HFO detection sufficient to warrant a more widespread interest in HFO? 

S15 | Brain Stimulation – Networks, Semiology, Clinical Value
Day: Friday, June 7
Scheduled hour: 08.00 – 09.30 *** New starting time
Chair / Organiser: Ioana Mîndruță

More info

1 ) Brain networks activated while performing high-frequency intracranial stimulation for functional cortical mapping. By Dr. Andrei Barborica, University of Bucharest, Physics Department, Bucharest, Romania.
2 ) Networks associated with clinical responses evoked by high-frequency intracranial stimulation. By Dr. Ioana Mindruta, University Emergency Hospital of Bucharest, Neurology Department, Bucharest, Romania.
3 ) Networks of ictal symptoms evoked by intracranial stimulation in patients with drug-resistant epilepsy explored through stereo-EEG method. By Dr. Irina Popa, University Emergency Hospital of Bucharest, Neurology Department, Bucharest, Romania

Session description: High-frequency intracranial stimulation is an essential method for mapping brain function. It is commonly considered that clinical effects result from tissue activation near the stimulation site. However, it may be possible that certain symptoms are the result from activation of broader networks. By using alternating stimulation polarity, we show that it is possible to overcome the stimulation artifact and identify brain networks activated during ~50Hz stimulation in 10 patients undergoing presurgical evaluation for drug-resistant epilepsy using stereo-EEG method. The activation of the networks at stimulation levels evoking a clinical symptom was compared with the below-threshold stimulation, that did not elicit any clinical effects, allowing to evidence a selective recruitment of pathways associated with a particular symptom. The method allowed identification of physiologic networks associated with various somatosensory, motor or language-related symptoms, among others. In addition, we selected patients in which typical ictal symptoms were elicited during stimulation using alternating polarity in several brain regions. Thus, networks underlying ictal symptoms in each patient were identified and then compared to ictal onset activation in order to determine the overlap between epileptogenic and symptomatogenic zone. As early clinical symptoms are the main indicators of the epileptogenic network, this work might play an important role in tailoring depth electrode implantation charts and surgical resections.

S16 | Muscle and Nerve Damage in Intensive Care: electrophysiological studies
Day: Friday, June 7
Scheduled hour: 13.30 – 15.00
Chair / Organiser: Mamede de Carvalho

More info

1 ) Neurophysiology of the respiratory muscles
Mamede De Carvalho ( Faculty of Medicine-Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal )
2 ) Axonal and muscle fiber excitability in intensive care neuromuscular dysfunction
Werner Z’Graggen ( Inselspital, University Hospital of Bern, Bern, Switzerland )
3 ) Strategies for investigating patients in ICU
Jean-Philippe Camdessanche ( Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France )

Neuromuscular dysfunction is increasingly recognized as a complication in patients cared in the intensive care unit (ICU). This condition is a predictor of mortality risk and is the most frequent cause of prolonged ventilator dependency. Risk factors for both intensive care myopathy and neuropathy are use of steroids, clinical severity, sepsis and multi-organ failure. Muscle lesion spectrum varies from sarcolema inexcitability and myofibrilhar destruction to muscle fibre necrosis. Axonal lesion is a less frequent cause of weakness in the intensive care setting, but can aggravate the manifestations derived from muscle fibre lesion damage. Diagnosis require clinical and laboratory evaluation. Electrodiagnostic testing is essential to evaluate the cause and severity of the intensive care neuromuscular dysfunction. In addition to conventional techniques to assess conduction velocity, spontaneous activity and morphology of motor unit potentials, novel techniques should be considered to investigate these patients. In this session, we aim to stress the importance of threshold technique to address muscle fibre and axonal membrane excitability, and to discuss the relevance of performing neurophysiological tests to investigate diaphragm function. In addition we intend to discuss the strategies to investigate these patients using the available neurophysiological armamentarium.

S17 | Facial Reinnervation and Function
Day: Friday, June 7
Scheduled hour: 13.30 – 15.00
Chair / Organiser: Hilmi Uysal

More info

1 ) What we have learned from full face transplantation? Hilmi Uysal, MD, Akdeniz University Faculty of Medicine, Department of Neurology, Antalya, Turkey.
2 ) Neurophysiological approach to rehabilitation after full face transplants Cagdas Topcu, MSc, Research Assistant, Faculty of Electronics, Telecommunications and Informatics, Gdansk University of Technology, Gdansk, Poland.
3 ) Scientific outlook on the advanced techniques for assessing the re-innervation after muscle transplantation. Both speakers, Hilmi Uysal and Cagdas Topcu.

Following up the reinnervation is a remarkable topic in full-face transplantation which usually completes within nine months. On the other hand, reinnervation does not mean to regain the complete function. Recovery of facial expressions improves the nonverbal communication, but reinnervation of muscle and skin is complex. Moreover, it is predictable to have plastic changes in primary and secondary association cortices following total loss of innervation. Face transplantation patients generally have different backgrounds and exhibit different degrees of sensorymotor improvement. Therefore, each case needs to be treated individually. The complexity of facial nerves and randomness of reinnervation may be responsible for unexpected observations of aberrant reinnervation and synkinesis after facial transplantation. In this symposium, we will present and discuss neurophysiological approach to individualized rehabilitation strategies after full-face transplantation

S18 | Neurophysiological evaluation in sleep disorders and neurodegeneration
Day: Friday, June 7
Scheduled hour: 13.30 – 15.00
Chair / Organiser: Poul Jennum

More info

Sleep disorder are common affecting a significant part of the population. Central for the diagnose is the polysomnographic (PSG) evaluation which is considered as the gold standard. The technology rely on decades of experiments, which however also have proven limitations primary due to the initial definition and manual scoring of the physiological measures. During the latest decades, significant advances have improved. In this symposium we focus on the medical and technical advantages which have appeared in 1) REM sleep Behavior Disorders (RBD) which are strongly associated with narcolepsy and alfasynucleino pathies, primarily Parkinson’s Disease PD, and 2) narcolepsy with cataplexy which have associated with loss of hypocretinergic neurons in the hypothalamus. We will discuss the current neurophysiological findings and evaluation for diagnosing these disorders. We will discuss both the use of traditional electrophysiological methods but also the use of advanced diagnostic methods taking the basic disease pathophysiological understanding into consideration.

1 ) RBD-marker for Parkinsonism. Importance of imaging techniques and pain perception. By Marit Otto. Associate professor, MD. Department of Clinical Neurophysiology, Århus University Hospital. Århus. Denmark.
2 ) Electrophysiologic markers for Narcolepsy. By Fabio Pizza. Associate Professor, MD. Department ofNeurology. University of Bologna. Bologna. Italy.
3 ) Neurophysiologic markers for sleep disorders. Implication of data-driven methods. By Poul Jørgen Jennum. Professor, chief physician, MD. Danish Center of Sleep Medicine, Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.

Session format for symposia

Based on a scientific theme, expanding cutting-edge knowledge for a topic culminating in a conclusion or summary.
Should be planned for 90 minutes and should include no more than three (3) speakers. All suggested speakers should agree with the proposal.
Should utilize a lecture style learning format.
The Scientific Program Committee shall make the final determination regarding the format and content.
Please provide the following information :
1) The title of your session proposal
2) The names and affiliations of each proposed speaker
3) The title of each speaker’s talk
4) A 200 words session description
All the proposals must be submitted through the online Symposia and EC Proposals form, available on this website.

Conditions of participation

The Congress organization will cover two nights’ accommodation and congress fee for the organizer of the symposium if he/she is also a speaker.
The Congress organization will cover the congress fee for the invited speakers ( maximum 3 speakers ).